最新报道:Humana Inc. (NYSE: HUM) reported mixed Q2 2025 results with adjusted EPS of $6.27, missing the $6.30 estimate, while revenue reached $29.97 billion, surpassing expectations. The health insurer's medical cost ratio rose to 88.3% from 86.4% YoY due to higher outpatient utilization, particularly in Medicare Advantage. Despite reaffirming its full-year adjusted EPS guidance of $16.00, Humana lowered its 2025 Medicare Advantage membership growth forecast to around 100,000 from 150,000, citing slower-than-expected enrollment trends. The company also announced a $2 billion accelerated share repurchase program. Shares fell 2.5% in premarket trading following the earnings release.